NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)

The summary for the NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01): -To accelerate the development and testing of new outcomes measures and instruments that could lead to improved trial designs or to the development of consensus about new instruments based on new or existing measures for diseases, illnesses and injuries of interest to the NIAMS. -This Funding Opportunity Announcement (FOA) solicits applications for research awards designed to develop, apply and evaluate new clinical trial outcomes measures of safety, efficacy and effectiveness of therapies. -The NIH U01 cooperative agreement mechanism will be utilized for this solicitation.

Federal Grant Title:	NIAMS Clinical Trial Outcomes Instrument Development Grant Program (U01)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AR-06-006
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.846
CFDA Descriptions:	Arthritis, Musculoskeletal and Skin Diseases Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Aug 30, 2006
Posted Date:	Jun 29, 2006
Creation Date:	Jun 29, 2006
Archive Date:	Sep 29, 2006
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:	$150,000
Minimum Federal Grant Award:
Expected Number of Awards:	5
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments State governments City or township governments For profit organizations other than small businesses Private institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities
Additional Information on Eligibility: Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. One application per applicant may be submitted in response to this RFA.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 ...; • Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 ...; • Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Cli...; • Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed); • NIAMS Skin Biology and Diseases Resource-based Centers (P30 - Clinical Trial Not Allowed); • Collaborative Arthritis and Musculoskeletal and Skin Diseases Science Award (Camssa); • Niams Small Grant Program for New Investigators; • Skin Diseases Research Core Centers
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...